$1.48
-0.07-4.52%
At close: -
$1.70
0.2214.86%
After Hours: Mar 18, 5:27 PM EDT
Comments
Loading...
SAB Biotherapeutics Stock Guidance | NASDAQ:SABS | Benzinga
SAB Biotherapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SAB Biotherapeutics Inc (SABS) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for SAB Biotherapeutics (SABS)?
There have been no specific sales or earnings guidance reported for SAB Biotherapeutics in recent months.
Browse guidance and forecast on all stocks.